FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Clears Expanding Orthopedics Cage

[ Price : $8.95]

FDA clears an Expanding Orthopedics 510(k) for the FLXfit 15 3D Expandable Cage System for restoring lumbar lordosis while control...

FDA Extending REMS to IR Opioids

[ Price : $8.95]

FDA commissioner Scott Gottlieb outlines additional steps the agency is taking to try to cut overall exposure to opioids.

Toxicity Testing, Labeling Guidance Out

[ Price : $8.95]

FDA publishes a draft guidance on reproductive toxicity assessments for anti-cancer drugs.

ANDA Deficiency Communication MAPP

[ Price : $8.95]

CDER issues a MAPP for ANDA filing reviewers on the procedure for communicating with applicants about submissions that contain min...

New Search Tool for FDA Adverse Events Database

[ Price : $8.95]

FDA launches a new search tool to improve access to data on drug and biologic adverse events through its Adverse Event Reporting S...

3 Dr. Reddys Inspection Observations

[ Price : $8.95]

FDA releases a FDA-483 issued to a Dr. Reddys drug manufacturing facility in the UK.

Status Report Review Form MAPP Out

[ Price : $8.95]

CDER publishes a MAPP on procedures and responsibilities for Office of New Drug completion and processing of annual status reports...

More Steps to Help Compounders Register for Outsourcing

[ Price : $8.95]

FDA releases two documents and plans more steps to help drug compounders register as outsourcing facilities.

Court Rejects Medtronic Fraud on FDA Case

[ Price : $8.95]

Hyman, Phelps attorneys say that a California federal court rejected a whistleblower suit against Medtronic over fraud-on-FDA and ...

Aurobindo Inspection Yields 2 Observations

[ Price : $8.95]

FDA releases a FDA-483 issued to Aurobindo Pharma following an inspection at its Hyderabad drug manufacturing facility.